Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymphatic vessels are thin-walled, valved tubular structures that form a crucial part of the lymphatic system. They transport lymph—a clear fluid containing immune cells, proteins, and waste products—away from tissues and return it to the bloodstream. The lymphatic vessel network is essential for maintaining fluid balance in the body, supporting immune function, and facilitating the absorption of dietary fats. Targeting molecules such as LYVE‑1 or VEGFR‑3 enables selective delivery to lymphatics for immunotherapy or cancer treatment applications.
Targeting lymphatic vessel endothelial cells (e.g., LYVE-1, VEGFR-3) for drug delivery or immunotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymphatic Vessel (N/A).